Rigel Pharma Jumps On Results From Rheumatoid Arthritis Drug - Wall Street Journal

The Money Times

Rigel Pharma Jumps On Results From Rheumatoid Arthritis Drug Wall Street Journal ... data on its second mid-stage study on its treatment for rheumatoid arthritis and saying it hopes to have a partner in place by the first half of 2010. ... Rigel says rheumatoid arthritis drug met goalCNBC Rigel shares rise on positive arthritis studyForbes Rigel's R788 Drug Improves RA SymptomsTheStreet.com Reuters -RTT News -Trading Markets (press release) all 55 news articles »

Arthritis Drug Raises Risk of Tuberculosis - Forbes

Arthritis Drug Raises Risk of Tuberculosis Forbes Their study examined the connection between TB and two anti-tumor necrosis factor (TNF) agents used to treat rheumatoid arthritis and other auto-immune ... and more »

Ask an Expert: Understanding Lupus - New York Times

New York Times

Ask an Expert: Understanding Lupus New York Times Many patients with related diseases, such as rheumatoid arthritis, have benefited in major ways from drugs that have been recently developed. ... and more »

New Rheumatoid Arthritis Drug in the Works - WebMD

Modern Medicine

New Rheumatoid Arthritis Drug in the Works WebMD June 29, 2009 -- An experimental drug called masitinib may ease rheumatoid arthritis symptoms in people who aren't helped by other drugs, ... New drug increases options for arthritis patientsguardian.co.uk Rheumatoid arthritis drug clears hurdleScience News Golimumab May Be Beneficial for Rheumatoid Arthritis Promising ...Modern Medicine DG News -Medical News Today -MedPage Today all 27 news articles »